Acelrx pharmaceuticals announces appointment of marina bozilenko to the board of directors

Redwood city, calif., march 31, 2021 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the appointment of marina bozilenko as an independent member of the company's board of directors.
ACRX Ratings Summary
ACRX Quant Ranking